Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

This study has been terminated.
(Low accrual--unable to meet accrual goals)
Sponsor:
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Georgetown University
ClinicalTrials.gov Identifier:
NCT01504477
First received: December 14, 2011
Last updated: February 12, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)